Ind-Swift Laboratories (NSE:INDSWFTLAB, BOM:532305) said its formulations facility in Derabassi, Punjab, has been granted a Good Manufacturing Practice (GMP) certificate by Hungary's National Center for Public Health and Pharmacy, according to an Indian bourse filing on Monday.
The certification follows an EUDRA GMP inspection conducted in November, the filing said. It is valid for three years and allows the company to access European and other regulated markets.
The facility already holds WHO-GMP, TGA (Australia), MHRA (UK), SAPRA (South Africa), and EU-GMP certifications, according to the filing.
Ind-Swift Laboratories' shares were down over 1% in Tuesday's trade.
Comments